These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
85 related articles for article (PubMed ID: 23170301)
21. [Correlation between subjective well-being and pharmacological therapy in patients with psychotic disorders]. Antonini V; Corradi A; Buizza C; Vittorielli M; Pioli R; Rossi G Recenti Prog Med; 2004 Dec; 95(12):581-4. PubMed ID: 15666490 [TBL] [Abstract][Full Text] [Related]
22. Efficacy of iloperidone in the short-term treatment of schizophrenia: a post hoc analysis of pooled patient data from four phase III, placebo- and active-controlled trials. Citrome L; Meng X; Hochfeld M; Stahl SM Hum Psychopharmacol; 2012 Jan; 27(1):24-32. PubMed ID: 22161738 [TBL] [Abstract][Full Text] [Related]
23. Cognitive and psychomotor effects of risperidone in schizophrenia and schizoaffective disorder. Houthoofd SA; Morrens M; Sabbe BG Clin Ther; 2008 Sep; 30(9):1565-89. PubMed ID: 18840365 [TBL] [Abstract][Full Text] [Related]
24. [The psychotic states in the psychiatric emergency]. Herbst L Vertex; 2002; 13 Suppl 1():22-7. PubMed ID: 12122424 [TBL] [Abstract][Full Text] [Related]
25. Acutely psychotic patients: a treatment approach. Wagemaker H; Lippmann S; Cade JR South Med J; 1985 Jul; 78(7):833-7. PubMed ID: 2861662 [TBL] [Abstract][Full Text] [Related]
26. Predicting medication-free treatment response in acute psychosis: cross-validation from the Finnish Need-Adapted Project. Bola JR; Lehtinen K; Aaltonen J; Räkköläinen V; Syvälahti E; Lehtinen V J Nerv Ment Dis; 2006 Oct; 194(10):732-9. PubMed ID: 17041284 [TBL] [Abstract][Full Text] [Related]
27. Nitric Oxide's Involvement in the Spectrum of Psychotic Disorders. Maia-de-Oliveira JP; Kandratavicius L; Nunes EA; Machado-de-Sousa JP; Hallak JE; Dursun SM Curr Med Chem; 2016; 23(24):2680-2691. PubMed ID: 27450675 [TBL] [Abstract][Full Text] [Related]
28. Schizoaffective disorder: a review of current research themes and pharmacological management. Kantrowitz JT; Citrome L CNS Drugs; 2011 Apr; 25(4):317-31. PubMed ID: 21284405 [TBL] [Abstract][Full Text] [Related]
29. Schizoaffective disorder: role of atypical antipsychotics. Keck PE; McElroy SL; Strakowski SM Schizophr Res; 1999 Mar; 35 Suppl():S5-12. PubMed ID: 10190221 [TBL] [Abstract][Full Text] [Related]
30. Exanthematous Rash With Lurasidone in an Elderly Woman With Schizoaffective Disorder. Hafeez ZH Prim Care Companion CNS Disord; 2019 Mar; 21(2):. PubMed ID: 30947406 [No Abstract] [Full Text] [Related]
31. Maintenance therapy for schizophreniform disorder. Stokes P; Steels M; Lee A Br J Psychiatry; 1994 Apr; 164(4):565. PubMed ID: 7913654 [No Abstract] [Full Text] [Related]
32. [Characteristics of the pharmacological pathomorphosis of remission in schizoaffective disorders]. Khritinin DF; Ivanets NN; Sumarokova MA Zh Nevrol Psikhiatr Im S S Korsakova; 2014; 114(7):23-9. PubMed ID: 25176262 [TBL] [Abstract][Full Text] [Related]
33. Fake views: Schizoaffective disorder is not 'SAD', just bad. Malhi GS; Bell E Aust N Z J Psychiatry; 2019 May; 53(5):481-484. PubMed ID: 31053053 [No Abstract] [Full Text] [Related]
34. Application of pharmacogenetics to psychotic disorders: the first consensus conference. The Consensus Group for Outcome Measures in Psychoses for Pharmacological Studies. Rietschel M; Kennedy JL; Macciardi F; Meltzer HY Schizophr Res; 1999 May; 37(2):191-6. PubMed ID: 10374654 [No Abstract] [Full Text] [Related]
35. Serine, glycine and carbohydrates in schizoaffective disorders. Bruinvels J; Pepplinkhuizen L Bibl Nutr Dieta; 1986; (38):168-72. PubMed ID: 3083807 [No Abstract] [Full Text] [Related]
38. [Disease and its course considered from a causative point of view]. Hecht A Zentralbl Allg Pathol; 1988; 134(6):575-81. PubMed ID: 3213292 [TBL] [Abstract][Full Text] [Related]
39. [Restitutio ad integrum of a focally infected tooth by conservative treatment]. SCHRAMM H Dtsch Stomatol; 1953 Jan; 3(1):18-20. PubMed ID: 13116781 [No Abstract] [Full Text] [Related]